Literature DB >> 8094166

Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs.

J L Vanherweghem1, M Depierreux, C Tielemans, D Abramowicz, M Dratwa, M Jadoul, C Richard, D Vandervelde, D Verbeelen, R Vanhaelen-Fastre.   

Abstract

Two similar cases of rapidly progressive fibrosing interstitial nephritis in young women who followed the same slimming regimen prompted us to conduct an epidemiological survey of the nephrology centres of Brussels and to further investigate the exact nature of this slimming treatment. Seven other women under the age of 50 in terminal or preterminal renal failure were admitted for dialysis in 1991 and 1992. They had all followed a slimming regimen in the same medical clinic. Renal biopsy samples in eight of the nine cases showed extensive interstitial fibrosis without glomerular lesions. Two of the patients were seen for the first time in terminal renal failure and were started immediately on dialysis. For the seven other women, the nephropathy was characterised by a rapid deterioration in renal function, with initial serum creatinine doubling within about 3 months. The clinic had specialised in slimming treatments for the previous 15 years without any problems. In May, 1990, therapy was changed, with the introduction of two Chinese herbs (Stephania tetrandra and Magnolia officinalis). In June, 1992, three of twenty-five randomly selected women who had followed the same regimen during at least 3 months from 1990 had impaired renal function. Chemical analysis of some brands of these Chinese herbs did not show nephrotoxic contaminants of fungal or plant origin (ochratoxin or aristolochic acid) or adulteration by diuretics or antiinflammatory drugs. However, the medicinal preparation of the capsules taken by patients had different alkaloid profiles from those expected in Chinese plants. The striking relation between a specific type of fibrosing interstitial nephritis in young women and a slimming treatment involving Chinese herbs adds support to the arguments against uncontrolled therapy with herbal preparations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094166     DOI: 10.1016/0140-6736(93)92984-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  211 in total

1.  Isogenic mesenchymal stem cells transplantation improves a rat model of chronic aristolochic acid nephropathy via upregulation of hepatic growth factor and downregulation of transforming growth factor β1.

Authors:  Wei Li; Hong Jiang; Jiang-Min Feng
Journal:  Mol Cell Biochem       Date:  2012-06-04       Impact factor: 3.396

2.  Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.

Authors:  Bojan Jelaković; Sandra Karanović; Ivana Vuković-Lela; Frederick Miller; Karen L Edwards; Jovan Nikolić; Karla Tomić; Neda Slade; Branko Brdar; Robert J Turesky; Želimir Stipančić; Damir Dittrich; Arthur P Grollman; Kathleen G Dickman
Journal:  Kidney Int       Date:  2011-11-09       Impact factor: 10.612

Review 3.  Chinese herbal medicines.

Authors:  Kevin V Ergil; Elizabeth J Kramer; Anthony T Ng
Journal:  West J Med       Date:  2002-09

4.  Perspective: Herbal dangers.

Authors:  Masatomo Sakurai
Journal:  Nature       Date:  2011-12-21       Impact factor: 49.962

Review 5.  Mammalian models of chemically induced primary malignancies exploitable for imaging-based preclinical theragnostic research.

Authors:  Yewei Liu; Ting Yin; Yuanbo Feng; Marlein Miranda Cona; Gang Huang; Jianjun Liu; Shaoli Song; Yansheng Jiang; Qian Xia; Johannes V Swinnen; Guy Bormans; Uwe Himmelreich; Raymond Oyen; Yicheng Ni
Journal:  Quant Imaging Med Surg       Date:  2015-10

6.  Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids.

Authors:  Wan Chan; Yufang Zheng; Zongwei Cai
Journal:  J Am Soc Mass Spectrom       Date:  2007-01-05       Impact factor: 3.109

Review 7.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

8.  Herbal supplements: considerations for the athletic trainer.

Authors:  A P Winterstein; C M Storrs
Journal:  J Athl Train       Date:  2001-10       Impact factor: 2.860

9.  Mapping the alternative route.

Authors:  Michael Day
Journal:  BMJ       Date:  2007-05-05

Review 10.  Genes and environment in chronic kidney disease hotspots.

Authors:  David J Friedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.